Antituberculosis treatment should be started immediately when the patient is diagnosed with tuberculosis, according to the principles of early, combined, appropriate, full and regular treatment, usually with tuberculosis drugs such as rifampin, isoniazid, ethambutol and pyrazinamide. Anti-TB treatment is administered according to the intensive and consolidation phases, and patients are usually treated for six months to one year. For drug-resistant TB and relapsed TB, second-line anti-TB drugs are used and the treatment course should be longer. The side effects caused by TB drugs should be noted and managed during anti-TB treatment, and some patients also require bronchoscopic intervention, as well as symptomatic management, especially for hemoptysis in TB patients. In conclusion, tuberculosis can be cured with active and effective anti-TB treatment, and few sequelae remain.